Drugs@FDA: FDA Approved Drug Products

Home | Previous Page

Abbreviated New Drug Application (ANDA): 202718
Company: TEVA PHARMS USA
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
MORPHINE SULFATE MORPHINE SULFATE 20MG CAPSULE, EXTENDED RELEASE;ORAL Prescription AB No No
MORPHINE SULFATE MORPHINE SULFATE 30MG CAPSULE, EXTENDED RELEASE;ORAL Prescription AB No No
MORPHINE SULFATE MORPHINE SULFATE 50MG CAPSULE, EXTENDED RELEASE;ORAL Prescription AB No No
MORPHINE SULFATE MORPHINE SULFATE 60MG CAPSULE, EXTENDED RELEASE;ORAL Prescription AB No No
MORPHINE SULFATE MORPHINE SULFATE 80MG CAPSULE, EXTENDED RELEASE;ORAL Prescription AB No No
MORPHINE SULFATE MORPHINE SULFATE 100MG CAPSULE, EXTENDED RELEASE;ORAL Prescription AB No No
MORPHINE SULFATE MORPHINE SULFATE 40MG CAPSULE, EXTENDED RELEASE;ORAL Prescription AB No No
MORPHINE SULFATE MORPHINE SULFATE 70MG CAPSULE, EXTENDED RELEASE;ORAL Prescription AB No No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
12/29/2014 ORIG-1 Approval Letter (PDF)

Label is not available on this site.

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/202718Orig1s000ltr.pdf
Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
09/18/2018 SUPPL-7 REMS - MODIFIED - D-N-A

Label is not available on this site.

05/26/2017 SUPPL-5 REMS-Modified

Label is not available on this site.

09/30/2016 SUPPL-4 REMS - MODIFIED - D-N-A

Label is not available on this site.

04/20/2016 SUPPL-3 REMS-Modified

Label is not available on this site.

06/26/2015 SUPPL-2 REMS-Modified

Label is not available on this site.

06/03/2015 SUPPL-1 Manufacturing (CMC)-New Strength

Label is not available on this site.

MORPHINE SULFATE

CAPSULE, EXTENDED RELEASE;ORAL; 20MG
TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
KADIAN MORPHINE SULFATE 20MG CAPSULE, EXTENDED RELEASE;ORAL Prescription Yes AB 020616 ALLERGAN
MORPHINE SULFATE MORPHINE SULFATE 20MG CAPSULE, EXTENDED RELEASE;ORAL Prescription No AB 200411 IMPAX LABS INC
MORPHINE SULFATE MORPHINE SULFATE 20MG CAPSULE, EXTENDED RELEASE;ORAL Prescription No AB 200812 PAR PHARM INC
MORPHINE SULFATE MORPHINE SULFATE 20MG CAPSULE, EXTENDED RELEASE;ORAL Prescription No AB 202718 TEVA PHARMS USA
MORPHINE SULFATE MORPHINE SULFATE 20MG CAPSULE, EXTENDED RELEASE;ORAL Prescription No AB 202104 UPSHER SMITH LABS

CAPSULE, EXTENDED RELEASE;ORAL; 30MG
TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
KADIAN MORPHINE SULFATE 30MG CAPSULE, EXTENDED RELEASE;ORAL Prescription Yes AB 020616 ALLERGAN
MORPHINE SULFATE MORPHINE SULFATE 30MG CAPSULE, EXTENDED RELEASE;ORAL Prescription No AB 200411 IMPAX LABS INC
MORPHINE SULFATE MORPHINE SULFATE 30MG CAPSULE, EXTENDED RELEASE;ORAL Prescription No AB 200812 PAR PHARM INC
MORPHINE SULFATE MORPHINE SULFATE 30MG CAPSULE, EXTENDED RELEASE;ORAL Prescription No AB 202718 TEVA PHARMS USA
MORPHINE SULFATE MORPHINE SULFATE 30MG CAPSULE, EXTENDED RELEASE;ORAL Prescription No AB 202104 UPSHER SMITH LABS

CAPSULE, EXTENDED RELEASE;ORAL; 50MG
TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
KADIAN MORPHINE SULFATE 50MG CAPSULE, EXTENDED RELEASE;ORAL Prescription Yes AB 020616 ALLERGAN
MORPHINE SULFATE MORPHINE SULFATE 50MG CAPSULE, EXTENDED RELEASE;ORAL Prescription No AB 200411 IMPAX LABS INC
MORPHINE SULFATE MORPHINE SULFATE 50MG CAPSULE, EXTENDED RELEASE;ORAL Prescription No AB 200812 PAR PHARM INC
MORPHINE SULFATE MORPHINE SULFATE 50MG CAPSULE, EXTENDED RELEASE;ORAL Prescription No AB 202718 TEVA PHARMS USA
MORPHINE SULFATE MORPHINE SULFATE 50MG CAPSULE, EXTENDED RELEASE;ORAL Prescription No AB 202104 UPSHER SMITH LABS

CAPSULE, EXTENDED RELEASE;ORAL; 60MG
TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
KADIAN MORPHINE SULFATE 60MG CAPSULE, EXTENDED RELEASE;ORAL Prescription Yes AB 020616 ALLERGAN
MORPHINE SULFATE MORPHINE SULFATE 60MG CAPSULE, EXTENDED RELEASE;ORAL Prescription No AB 200411 IMPAX LABS INC
MORPHINE SULFATE MORPHINE SULFATE 60MG CAPSULE, EXTENDED RELEASE;ORAL Prescription No AB 200812 PAR PHARM INC
MORPHINE SULFATE MORPHINE SULFATE 60MG CAPSULE, EXTENDED RELEASE;ORAL Prescription No AB 202718 TEVA PHARMS USA
MORPHINE SULFATE MORPHINE SULFATE 60MG CAPSULE, EXTENDED RELEASE;ORAL Prescription No AB 202104 UPSHER SMITH LABS

CAPSULE, EXTENDED RELEASE;ORAL; 80MG
TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
KADIAN MORPHINE SULFATE 80MG CAPSULE, EXTENDED RELEASE;ORAL Prescription Yes AB 020616 ALLERGAN
MORPHINE SULFATE MORPHINE SULFATE 80MG CAPSULE, EXTENDED RELEASE;ORAL Prescription No AB 200411 IMPAX LABS INC
MORPHINE SULFATE MORPHINE SULFATE 80MG CAPSULE, EXTENDED RELEASE;ORAL Prescription No AB 200812 PAR PHARM INC
MORPHINE SULFATE MORPHINE SULFATE 80MG CAPSULE, EXTENDED RELEASE;ORAL Prescription No AB 202718 TEVA PHARMS USA
MORPHINE SULFATE MORPHINE SULFATE 80MG CAPSULE, EXTENDED RELEASE;ORAL Prescription No AB 202104 UPSHER SMITH LABS

CAPSULE, EXTENDED RELEASE;ORAL; 100MG
TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
KADIAN MORPHINE SULFATE 100MG CAPSULE, EXTENDED RELEASE;ORAL Prescription Yes AB 020616 ALLERGAN
MORPHINE SULFATE MORPHINE SULFATE 100MG CAPSULE, EXTENDED RELEASE;ORAL Prescription No AB 200411 IMPAX LABS INC
MORPHINE SULFATE MORPHINE SULFATE 100MG CAPSULE, EXTENDED RELEASE;ORAL Prescription No AB 200812 PAR PHARM INC
MORPHINE SULFATE MORPHINE SULFATE 100MG CAPSULE, EXTENDED RELEASE;ORAL Prescription No AB 202718 TEVA PHARMS USA
MORPHINE SULFATE MORPHINE SULFATE 100MG CAPSULE, EXTENDED RELEASE;ORAL Prescription No AB 202104 UPSHER SMITH LABS

CAPSULE, EXTENDED RELEASE;ORAL; 40MG
TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
KADIAN MORPHINE SULFATE 40MG CAPSULE, EXTENDED RELEASE;ORAL Prescription Yes AB 020616 ALLERGAN
MORPHINE SULFATE MORPHINE SULFATE 40MG CAPSULE, EXTENDED RELEASE;ORAL Prescription No AB 202718 TEVA PHARMS USA

CAPSULE, EXTENDED RELEASE;ORAL; 70MG
TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
KADIAN MORPHINE SULFATE 70MG CAPSULE, EXTENDED RELEASE;ORAL Prescription Yes AB 020616 ALLERGAN
MORPHINE SULFATE MORPHINE SULFATE 70MG CAPSULE, EXTENDED RELEASE;ORAL Prescription No AB 202718 TEVA PHARMS USA

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English